Holen Sie sich die Stockscreener-App
21.43
1.90%
0.40
Vorhandelsmarkt:
21.43
Schlusskurs vom Vortag:
$21.03
Offen:
$21.8
24-Stunden-Volumen:
335.72K
Relative Volume:
0.91
Marktkapitalisierung:
$5.85B
Einnahmen:
$1.40B
Nettoeinkommen (Verlust:
$164.00M
KGV:
35.66
EPS:
0.6009
Netto-Cashflow:
$-11.09M
1W Leistung:
-3.77%
1M Leistung:
+8.07%
6M Leistung:
+38.08%
1J Leistung:
-6.87%
1-Tages-Spanne:
$20.93
$21.80
1-Wochen-Bereich:
$20.86
$23.08
52-Wochen-Spanne:
$12.89
$28.00
Stevanato Group Spa Stock (STVN) Company Profile
Compare STVN vs ISRG, BDX, ALC, RMD, MDLN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
STVN
Stevanato Group Spa
|
21.43 | 6.10B | 1.40B | 164.00M | -11.09M | 0.6009 |
ISRG
Intuitive Surgical Inc
|
376.86 | 132.30B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
188.11 | 51.11B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
72.06 | 35.25B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
240.10 | 32.95B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
35.03 | 28.58B | 29.14B | 1.07B | 1.05B | 1.1956 |
Stevanato Group Spa Stock (STVN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2024-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2024-12-03 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2024-04-22 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-11-01 | Herabstufung | Jefferies | Buy → Hold |
| 2023-09-26 | Eingeleitet | Stephens | Overweight |
| 2023-09-19 | Eingeleitet | CJS Securities | Market Outperform |
| 2023-08-24 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-08-10 | Eingeleitet | BofA Securities | Buy |
| 2021-08-10 | Eingeleitet | Citigroup | Buy |
| 2021-08-10 | Eingeleitet | Jefferies | Buy |
| 2021-08-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2021-08-10 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-08-10 | Eingeleitet | Wells Fargo | Overweight |
Alle ansehen
Stevanato Group Spa Aktie (STVN) Neueste Nachrichten
Stevanato (STVN) Q2 2026 Filing Snapshot: EPS Prints Above Forecast in Latest Trading; Share-Price Check: Shares Finish 0.28% Lower in the Latest ReadingEBITDA Analysis - vinanet.vn
Stevanato Group (STVN) Edges Higher to $21.19, Holding Between Key Support and ResistanceGap Down Bounce Plays - Vinanet
Stevanato Group S.p.A. (STVN) Stock Analysis: A Solid Healthcare Play with a 17.46% Upside Potential - DirectorsTalk Interviews
T. Rowe Price (STVN) cuts Stevanato stake to 3,921 shares, 0.0% - Stock Titan
Artisan Partners (STVN) discloses 2.6M Stevanato shares held for clients - Stock Titan
Stevanato Group S.p.A. (STVN) Stock Forecasts - Yahoo! Finance Canada
Royal Bank of Canada Grows Stock Position in Stevanato Group S.p.A. $STVN - MarketBeat
Trading the Move, Not the Narrative: (STVN) Edition - Stock Traders Daily
Stevanato Group S.p.A. (NYSE:STVN) Receives Consensus Recommendation of "Buy" from Brokerages - MarketBeat
Stevanato Group (STVN) Advances 1.94% as Drug Delivery Specialist Holds Above Key SupportFloat Adjusted Cap - Vinanet
Stevanato Group (STVN) Could Be 16% Undervalued Following Earnings And Guidance Update - finance.yahoo.com
How Q2 Results and Alina GLP-1 Approvals At Stevanato Group (STVN) Have Changed Its Investment Story - Sahm
Stevanato Group (NYSE:STVN) Director Luciano Santel Sells 2,023 Shares of Stock - MarketBeat
Stevanato Group Director Elisabetta Magistretti Sells Shares to Meet Tax Obligations - Kalkine Media
Stevanato Group (STVN) Stock Looks Cheap On Cash Flow But Pricey On Earnings - finance.yahoo.com
Stevanato Group S.p.A. (STVN): Investor Outlook Reveals 23.83% Potential Upside - DirectorsTalk Interviews
Stevanato Group CFO Marco Dal Lago Sells Shares to Meet Tax Liabilities - Kalkine Media
Stevanato Group Q2 Earnings Call Highlights - MarketBeat
Stevanato Group (STVN) Holds Near $20.27 as Range-Bound Trading PersistsFactor Momentum - vinanet.vn
Stevanato Group S.p.A. SEC Filing (Aug 7, 2026) - Stock Titan
Liraglutide combination products using Stevanato Group pen gain European approval - Drug Store News
Stevanato Group SpA (STVN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Stevanato Group (NYSE: STVN) targets 26.8% 2026 EBITDA margin - Stock Titan
Stevanato Group SpA Revenue Breakdown – DUS:87N - TradingView
Stevanato Group Details Mid-2026 Performance and Risk Landscape in Unaudited Interim Report - The Globe and Mail
Stevanato Group Q2 2026 Earnings Call: Complete Transcript - Sahm
Stevanato Group S.p.A. Stock 12‑Month Price Target Raised to $25.1, Implies 28% Upside - TradingView
Is Stevanato (STVN) a Solid Growth Stock? 3 Reasons to Think "Yes" - Yahoo Finance
335,493 Shares in Stevanato Group S.p.A. $STVN Purchased by Confluence Investment Management LLC - MarketBeat
Lazard Asset Management LLC Purchases New Position in Stevanato Group S.p.A. $STVN - marketbeat.com
Stevanato (STVN) Q2 2026 Earnings Call Transcript - The Globe and Mail
Stevanato Group S.p.A. Q2 2026 Earnings Call Summary - Yahoo Finance
Stevanato Group SpA Revenue Breakdown – MUN:87N - TradingView
Craftech Holdco acquired Balda C. Brewer, Inc. from Stevanato Group S.p.A.. - marketscreener.com
Stevanato Group (NYSE: STVN) grows H1 revenue, records disposal loss - Stock Titan
Stevanato Group (NYSE: STVN) grows Q2 sales 8% and updates 2026 view - Stock Titan
Stevanato Group (NYSE: STVN) grows Q2 revenue and sells Balda subsidiary - stocktitan.net
Van Berkom & Associates (STVN) discloses 5.97% stake in Stevanato Group - Stock Titan
Stevanato Group Delivers 8% Revenue Growth for the Second Quarter of Fiscal 2026 - Stevanato Group S.p.A. (STVN)
Stevanato Group (NYSE:STVN) Stock Price Down 5.1%Should You Sell? - MarketBeat
Transcript : Stevanato Group S.p.A., Q2 2026 Earnings Call, Aug 04, 2026 - marketscreener.com
Stevanato Group (NYSE:STVN) Releases Earnings Results, Beats Expectations By $0.01 EPS - MarketBeat
Stevanato Group (NYSE:STVN) Updates FY 2026 Earnings Guidance - marketbeat.com
Stevanato Q2 2026 slides: biologics push lifts margins, FCF negative - Investing.com
Earnings call transcript: Stevanato Group tops Q2 2026 estimates, shares fall - Investing.com Nigeria
Sage Park expands medical molding platform as it buys Balda C. Brewer’s California plant - Plastics News
Sage Park Acquires Balda C. Brewer, the California-based Contract Manufacturing Injection Molding Subsidiary From Stevanato Group S.p.A. - Moomoo
Stevanato Q2 Adjusted Earnings, Revenue Rise; Updates 2026 Guidance - marketscreener.com
Stevanato Group Q2 2026 Earnings Call Transcript - MarketBeat
Stevanato Group S.p.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Stevanato Group SpA earnings beat by €0.01, revenue topped estimates - Investing.com
Finanzdaten der Stevanato Group Spa-Aktie (STVN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Stevanato Group Spa-Aktie (STVN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Dal Lago Marco | Chief Financial Officer |
Aug 07 '26 |
Sale |
20.09 |
4,209 |
84,559 |
81,144 |
| Magistretti Elisabetta | Director |
Aug 07 '26 |
Sale |
20.09 |
2,045 |
41,084 |
2,930 |
1.40%
0.50%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):